Massachusetts Weekly: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Massachusetts Weekly.

Press releases published on May 26, 2026

Choroideremia Research Foundation Announces June 30 Research Grant Application Deadline
Innovative, Life Changing TMS Therapy at Northeast Health Services' Boston Government Center Clinic
POS Supply Solutions Expands Product Line & Rebrands POS Sticky Labels as QuickStick Receipt Labels for Restaurants/QSRs
Hanover High School Senior Ava Khouri Publishes Inspiring Children’s Book: The Apple of My Pie
The Cottagers Incorporated of Martha's Vineyard Celebrate 70 Years of Service and Giving
This Men's Mental Health Month, Boston Gynecomastia Specialists highlights Gynecomastia’s impact on men’s mental health
New England Patriots RB TreVeyon Henderson Stars in Announcement Video as Gripped Book Series Heads to Television
UltraSight™ Study Shows Novices Achieve Diagnostic-Quality Cardiac Ultrasound After One Day of AI-Guided Training
Stanford Study Finds Contingency Management Highly Cost-Effective for Methamphetamine Use Disorder
BREAKING: Verra Mobility Shares Plummet Following Termination of Avis Agreement; Investors Should Contact Block & Leviton to Possibly Recover Losses
Caswell Plumbing and Heating Recognized as Top Rated Plumber in Framingham, MA by Best of 2026 BusinessRate
Destination XL Group, Inc. Recommends DXL Shareholders Reject Zodiac Partners II’s Tender Offer And NOT Tender Their Shares
Spyre Therapeutics to Participate in Upcoming June Investor Conferences
Jade Biosciences Announces First Participant Dosed in First-in-Human Phase 1 Clinical Trial of JADE201, a Novel Half-Life Extended Afucosylated Anti-BAFF Receptor Monoclonal Antibody
CarGurus to Present at the BofA Securities 2026 Global Technology Conference
Kailera Reports First Quarter 2026 Financial Results and Provides Clinical Data Updates
Apogee Therapeutics to Host Conference Call to Report Part B 16-Week Data from the Phase 2 APEX Trial of Zumilokibart in Patients with Moderate-to-Severe Atopic Dermatitis on May 27, 2026
Molecular Partners to Present at TD Cowen’s 7th Annual Oncology Innovation Summit
Gordon Brothers Acquires Radley Brand
Astra Tower Achieves LEED Gold Certification, Advancing Sustainable Living in Salt Lake City

Share this page:

Sign up for:

Massachusetts Weekly

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.